Inhibition of Bruton's tyrosine kinase regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation
Background and Purpose Currently there are limited medicines available for the treatment of metabolic inflammation in diseases such as obesity and type 2 diabetes (T2D). Although initially associated with B‐ells, Bruton's tyrosine kinase (BTK) is present in a wide variety of cells including mon...
Автори: | Purvis, GSD, Collino, M, Aranda-Tavio, H, Chiazza, F, O'Riordan, CE, Zeboudj, L, Mohammad, S, Collotta, D, Verta, R, Guisot, NES, Bunyard, P, Yaqoob, MM, Greaves, DR, Thiemermann, C |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Wiley
2020
|
Схожі ресурси
Схожі ресурси
-
Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
за авторством: O'Riordan, CE, та інші
Опубліковано: (2019) -
X-linked immunodeficient mice with no functional Bruton's tyrosine kinase are protected from sepsis-induced multiple organ failure
за авторством: O'Riordan, CE, та інші
Опубліковано: (2020) -
Bruton's TK regulates myeloid cell recruitment during acute inflammation
за авторством: Purvis, GSD, та інші
Опубліковано: (2022) -
Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice
за авторством: Caroline E. O'Riordan, та інші
Опубліковано: (2019-09-01) -
Brutinib has anti‐inflammatory and anti‐diabetic effects in a model of HFD‐ induced insulin resistance and diabetic nephropathy
за авторством: Purvis, GS, та інші
Опубліковано: (2019)